LLS Announces Collaboration With the National Cancer Institute and Children's Oncology Group on a Global Master Clinical Trial for Children With Acute Leukemia
June 19, 2020
June 19, 2020
RYE BROOK, New York, June 19 -- The Leukemia and Lymphoma Society issued the following news release:
The Leukemia & Lymphoma Society (LLS) announced a collaboration with the National Cancer Institute (NCI) and the Children's Oncology Group (COG) to launch a global precision medicine clinical trial for children with acute leukemia. The three organizations share a commitment to address the urgent need for new, more precise and more effective treatments for children with cancer.
The Leukemia & Lymphoma Society (LLS) announced a collaboration with the National Cancer Institute (NCI) and the Children's Oncology Group (COG) to launch a global precision medicine clinical trial for children with acute leukemia. The three organizations share a commitment to address the urgent need for new, more precise and more effective treatments for children with cancer.